Jack Denham

Jack Denham is the CEO and Chairman of the Board of EuroCorp. He is known to take a direct interest in EuroCorp's agent creation program, and has developed close relationships to the agents assigned to him directly.

History
Jack Denham was born when governments and politicians were still the norm, coming from a family of lawmakers and corporate leaders. When he was still a young man, his mother committed suicide after lurid press coverage of an illicit affair, and his father retreated into his work.

His father, Jonathan Denham, was a judge in the US Supreme Court. Before his death from cancer in 2019, he managed the case of Shiawase Corporation v. Nuclear Regulatory Commission, better known as the Shiawase Decision, which created extraterritorial rights for megacorporations.

During university, Denham engaged in social studies, psychology and economics, publishing multiple articles about how individuality corrupts social structures. As the megacorporations arose as a global force,  he embraced the change as the replacement of the mother and father he'd lost.

Denham specialized early in corporate security systems and biotech, and also made a name for himself as a savagely efficient field operative, extracting and interrogating rival executives personally.

He has been with EuroCorp since shortly after its founding, rising to the position as CEO after nearly five decades as an executive. Outside of his role as CEO, Denham is a family man, married with three children, all of whom are involved in the upper levels of EuroCorp's corporate structure. Though many of his detractors accuse Denham of nepotism, independent research indicates that Denham's children earned their places through merit as much as birthright.

Rumors circulate that Denham has undergone leonization treatment to arrest the effects of aging as he nears his ninth decade, though these rumors are nearly impossible to substantiate, as EuroCorp's personnel files for its top leadership are kept extremely secure.